FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

G Y H Lip

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Anatomy

Co-author Network

Publications

TOP 3
R De Caterina; K Huber; S Husted; J Jespersen; S D Kristensen; G Y H Lip; J Morais; L H Rasmussen; A Siegbahn; F W A Verheugt; L Wallentin; F Andreotti; H Arnesen; F Bachmann; Colin Baigent; J I Weitz
Parenteral anticoagulants in heart disease: Current status and perspectives (Section II). Position Paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease.
V Roldán; M Valdés; V Vicente; H Fernández; P Gallego; S Manzano-Fernandez; F Marín; G Y H Lip
Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?
B Anandasundaram; S Apostolakis; D A Lane; G Y H Lip
The impact of atherosclerotic vascular disease in predicting a stroke, thromboembolism and mortality in atrial fibrillation patients: a systematic review.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of G Y H Lip (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: R De Caterina; K Huber; S Husted; J Jespersen; S D Kristensen; G Y H Lip; J Morais; L H Rasmussen; A Siegbahn; F W A Verheugt; L Wallentin; F Andreotti; H Arnesen; F Bachmann; Colin Baigent; J I Weitz
Parenteral anticoagulants in heart disease: Current status and perspectives (Section II). Position Paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease.
Thrombosis and haemostasis 2013;109(5):769-86.
2013: V Roldán; M Valdés; V Vicente; H Fernández; P Gallego; S Manzano-Fernandez; F Marín; G Y H Lip
Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?
Thrombosis and haemostasis 2013;109(5):956-60.
2013: B Anandasundaram; S Apostolakis; D A Lane; G Y H Lip
The impact of atherosclerotic vascular disease in predicting a stroke, thromboembolism and mortality in atrial fibrillation patients: a systematic review.
Journal of thrombosis and haemostasis : JTH 2013;11(5):975-87.
2013: L V Andersen; Jes S Lindholt; G Y H Lip; L Frost
Upper limb arterial thromboembolism: a systematic review on incidence, risk factors, and prognosis, including a meta-analysis of risk-modifying drugs.
Journal of thrombosis and haemostasis : JTH 2013;11(5):836-44.
2013: R De Caterina; K Huber; S Husted; J Jespersen; S D Kristensen; G Y H Lip; J Morais; L H Rasmussen; A Siegbahn; F W A Verheugt; L Wallentin; F Andreotti; H Arnesen; F Bachmann; Colin Baigent; J I Weitz
General mechanisms of coagulation and targets of anticoagulants (Section I). Position Paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease.
Thrombosis and haemostasis 2013;109(4):569-79.
2013: G Y H Lip
Recommendations for thromboprophylaxis in the 2012 focused update of the ESC guidelines on atrial fibrillation: a commentary.
Journal of thrombosis and haemostasis : JTH 2013;11(4):615-26.
2013: William M O'Neil; Sharon A Welner; G Y H Lip
Do open label blinded outcome studies of novel anticoagulants versus warfarin have equivalent validity to those carried out under double-blind conditions?
Thrombosis and haemostasis 2013;109(3):497-503.
2013: L D Tapp; B J Wrigley; S Montoro-Garcia; Eduard Shantsila; G Y H Lip
TLR4 expression on monocyte subsets in myocardial infarction.
Journal of internal medicine 2013;273(3):294-305.
2013: Eduard Shantsila; Luke D Tapp; Benjamin J Wrigley; Silvia Montoro-García; G Y H Lip
CXCR4 positive and angiogenic monocytes in myocardial infarction.
Thrombosis and haemostasis 2013;109(2):255-62.
2013: Ron Pisters; Robby Nieuwlaat; Harry J G M Crijns; Deirdre A Lane; G Y H Lip
Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation. A modelling analysis from the Euro Heart Survey.
Thrombosis and haemostasis 2013;109(2):328-36.
2013: V J Karthikeyan; D A Lane; G Y H Lip; D G Beevers; A D Blann
Matrix metalloproteinases and their tissue inhibitors in hypertension-related pregnancy complications.
Journal of human hypertension 2013;27(2):72-8.
2012: G Y H Lip; Francisco Marín; Joao Morais; Piotr Piotrponikowski; Patrick Pullicino; Lars H Rasmussen; Felicita Andreotti; Stefan D Anker; Gerasimos Filippatos; Shunichi Homma; Deirdre A Lane
Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm: an executive summary of a joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis.
Thrombosis and haemostasis 2012;108(6):1009-22.
2012: Diana Hernández-Romero; F Marín; Vanessa Roldán; G Y H Lip
Subclinical atherosclerotic endothelial damage as predictor for bleeding in anticoagulated atrial fibrillation patients.
Journal of internal medicine 2012;272(4):409.
2012: A D Blann; N Kuzniatsova; S Velu; G Y H Lip
Renal function and aspirin resistance in patients with coronary artery disease.
Thrombosis research 2012;130(3):e103-6.
2012: A P Mikkelsen; G H Gislason; J Lindhardsen; G Y H Lip; C Torp-Pedersen; J B Olesen
Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study.
Journal of thrombosis and haemostasis : JTH 2012;10(9):1745-51.
2012: J Harenberg; G Y H Lip; V J Marder; S Marx; M Wehling; H-C Diener; C Weiss
Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis.
International angiology : a journal of the International Union of Angiology 2012;31(4):330-9.
2012: Silvia Montoro-García; Esteban Orenes-Piñero; Eduard Shantsila; María Luisa Lozano; G Y H Lip
An innovative flow cytometric approach for small-size platelet microparticles: influence of calcium.
Thrombosis and haemostasis 2012;108(2):373-83.
2012: Vanessa Roldán; M Romera; Mariano Valdés; Vicente Vicente; Teresa Casas; J Díaz; P Gallego; E Jover; S Manzano-Fernández; Francisco Marin; G Y H Lip
High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation.
Journal of thrombosis and haemostasis : JTH 2012;10(8):1500-7.
2012: Eduard Shantsila; Luke D Tapp; Benjamin J Wrigley; Stavros Apostolakis; Silvia Montoro-García; G Y H Lip
Fibrinolytic status in acute coronary syndromes: evidence of differences in relation to clinical features and pathophysiological pathways.
Thrombosis and haemostasis 2012;108(1):32-40.
2012: Eduard Shantsila; L D Tapp; B J Wrigley; P S Gill; A Shantsila; G Y H Lip
Monocyte-derived and CD34+/KDR+ endothelial progenitor cells in heart failure.
Journal of thrombosis and haemostasis : JTH 2012;10(7):1252-61.
2012: L D Tapp; B J Wrigley; B Pamukcu; Eduard Shantsila; G Y H Lip
The CD14++CD16+ monocyte subset and monocyte-platelet interactions in patients with ST-elevation myocardial infarction.
Journal of thrombosis and haemostasis : JTH 2012;10(7):1231-41.
2012: Jonas Bjerring Olesen; Christian Torp-Pedersen; Morten Lock Hansen; G Y H Lip
The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.
Thrombosis and haemostasis 2012;107(6):1172-9.
2012: J Foley; G Y H Lip
Do the current atrial fibrillation guidelines for stroke prevention need to be changed with the availability of new data on the new oral anticoagulants?
International journal of clinical practice 2012;66(5):422-4.
2012: Menno V Huisman; G Y H Lip; Joanne van Ryn; Martina Brueckmann; Hans-Christoph Diener; Andreas Clemens
Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: resolving uncertainties in routine practice.
Thrombosis and haemostasis 2012;107(5):838-47.
2012: Amitava Banerjee; Deirdre A Lane; Christian Torp-Pedersen; G Y H Lip
Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a 'real world' atrial fibrillation population: a modelling analysis based on a nationwide cohort study.
Thrombosis and haemostasis 2012;107(3):584-9.
2012: A Shantsila; G Y H Lip
Silent cerebral embolism after catheter ablation of atrial fibrillation.
International journal of clinical practice 2012;66(2):118-20.
2012: A Banerjee; G Y H Lip
Improving the diagnosis and prognosis of atrial fibrillation in stroke: quo vadis?
European journal of neurology : the official journal of the European Federation of Neurological Societies 2012;19(2):187-8.
2011: Eduard Shantsila; G Y H Lip; P S Gill
Systolic heart failure in South Asians.
International journal of clinical practice 2011;65(12):1274-82.
2011: I S Toor; W Dimitri; Rumi J Jaumdally; G Y H Lip; TA Millane; D Pagano; Chetan Varma
Differences between South Asians and White Europeans in five year outcome following percutaneous coronary intervention.
International journal of clinical practice 2011;65(12):1259-66.
2011: G Y H Lip; Francisco Marín; Gualtiero Palareti; Felicita Andreotti; Laurent Fauchier; Kurt Huber; Elaine Hylek; Paulus Kirchhof; Eve Knight; Deirdre Lane; Marcel Levi
Bleeding risk assessment and management in atrial fibrillation patients. Executive Summary of a Position Document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on Thrombosis.
Thrombosis and haemostasis 2011;106(6):997-1011.
2011: Paulus Kirchhof; Deirdre Lane; G Y H Lip; Luis Mont; Ulrich Schotten; Isabelle C Van Gelder; Panos Vardas; Karl Wegscheider; Stephan Willems; Jeroen Bax; Giuseppe Boriani; Günter Breithardt; Hans Diener; Paul Dorian; Michael Ezekowitz; Hein Heidbuchel; Elaine Hylek; Stefan Kääb; A John Camm
Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNET/EHRA consensus conference.
Thrombosis and haemostasis 2011;106(6):1012-9.
2011: D Kaireviciute; Gintaras Kalinauskas; G Y H Lip; M Maheshwari; Gediminas Norkunas; H Sihota; Vytautas Sirvydis; Giedrius Uzdavinys; U Zanetto; A Aidietis; B Balakrishnan; Andrew D Blann
Intracardiac expression of markers of endothelial damage/dysfunction, inflammation, thrombosis, and tissue remodeling, and the development of postoperative atrial fibrillation.
Journal of thrombosis and haemostasis : JTH 2011;9(12):2345-52.
2011: T S Potpara; Bosiljka Vujisic-Tesic; M M Licina; J M Marinkovic; N M Mujovic; M Petrovic; M M Polovina; G Y H Lip
The impact of dilated left atrium on rhythm control in patients with newly diagnosed persistent atrial fibrillation: the Belgrade atrial fibrillation project.
International journal of clinical practice 2011;65(11):1202-3.
2011: S Apostolakis; G Y H Lip
Stroke prevention in non-valvular atrial fibrillation: can warfarin do better?
Thrombosis and haemostasis 2011;106(5):753-4.
2011: T S Potpara; G Y H Lip
New anticoagulation drugs for atrial fibrillation.
Clinical pharmacology and therapeutics 2011;90(4):502-6.
2011: Kurt Huber; K Juhani Airaksinen; Thomas Cuisset; Francisco Marín; Andrea Rubboli; G Y H Lip
Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: similarities and dissimilarities between North America and Europe.
Thrombosis and haemostasis 2011;106(4):569-71.
2011: Jonas Bjerring Olesen; Jakob Raunsø; Janne Schurmann Tolstrup; Ole Ahlehoff; Gunnar Hilmar Gislason; Morten Lock Hansen; Peter Riis Hansen; Deirdre A Lane; Jesper Lindhardsen; G Y H Lip; Christian Torp-Pedersen
Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a 'real world' nationwide cohort study.
Thrombosis and haemostasis 2011;106(4):739-49.
2011: L V Andersen; Ole Faergeman; Eskild W Henneberg; Jes S Lindholt; G Y H Lip; L S Mortensen; L Frost
Atrial fibrillation and upper limb thromboembolectomy: a national cohort study.
Journal of thrombosis and haemostasis : JTH 2011;9(9):1738-43.
2011: J B Olesen; P Weeke; O Ahlehoff; C Andersson; G H Gislason; M L Hansen; P R Hansen; J Lindhardsen; G Y H Lip; C Torp-Pedersen
Bleeding risk in 'real world' patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort.
Journal of thrombosis and haemostasis : JTH 2011;9(8):1460-7.
2011: A Banerjee; D A Lane; G Y H Lip
Bleeding risk with oral anticoagulation--new frontiers and new questions.
International journal of clinical practice 2011;65(7):719-21.
2011: Isla M Ogilvie; Sharon A Welner; Warren Cowell; G Y H Lip
Ischaemic stroke and bleeding rates in 'real-world' atrial fibrillation patients.
Thrombosis and haemostasis 2011;106(1):34-44.
2011: L H Rasmussen; A Tjønneland; K M Due; T B Larsen; K Overvad; G Y H Lip
Impact of vascular disease in predicting stroke and death in patients with atrial fibrillation: the Danish Diet, Cancer and Health cohort study.
Journal of thrombosis and haemostasis : JTH 2011;9(7):1301-7.
2011: A D Blann; D Luesley; K S Ramcharan; Paul S Stonelake; G Y H Lip
The angiome: a new concept in cancer biology.
Journal of clinical pathology 2011;64(7):637-43.
2011: Andrew D Blann; B Balakrishnan; Peter Ryan; G Y H Lip
Increased levels of plasma haemoxygenase-1 in prostate cancer.
Prostate cancer and prostatic diseases 2011;14(2):114-7.
2011: Eduard Shantsila; B Wrigley; L Tapp; S Apostolakis; S Montoro-Garcia; M T Drayson; G Y H Lip
Immunophenotypic characterization of human monocyte subsets: possible implications for cardiovascular disease pathophysiology.
Journal of thrombosis and haemostasis : JTH 2011;9(5):1056-66.
2011: B R Disney; R D S Watson; A D Blann; G Y H Lip; M R Anderson
Review article: proton pump inhibitors with clopidogrel--evidence for and against a clinically-important interaction.
Alimentary pharmacology & therapeutics 2011;33(7):758-67.
2011: P C Bennett; P S Gill; S Silverman; Andrew D Blann; J Chackathayil; G Y H Lip
Hemostatic cardiovascular risk factors, common carotid-intima medial thickness and peripheral arterial disease in South Asians and African Caribbeans: a substudy to the Ethnic-Echocardiographic Heart of England Screening (E-ECHOES) study.
Journal of thrombosis and haemostasis : JTH 2011;9(4):645-52.
2011: Ingo Ahrens; G Y H Lip; Karlheinz Peter
What do the RE-LY, AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation?
Thrombosis and haemostasis 2011;105(4):574-8.
2011: Tatjana Potpara; G Y H Lip
Lone atrial fibrillation: what is known and what is to come.
International journal of clinical practice 2011;65(4):446-57.
2011: G Y H Lip; O M Durrani; V Roldan; PL Lip; F Marin; T Q Reuser
Peri-operative management of ophthalmic patients taking antithrombotic therapy.
International journal of clinical practice 2011;65(3):361-71.
2011: Eduard Shantsila; G Y H Lip
Monocytes: possible mediators of benefits and harms from physical activity?
Thrombosis and haemostasis 2011;105(3):387-9.
2011: P C Bennett; P S Gill; S Silverman; Andrew D Blann; G Y H Lip
Ethnic differences in common carotid intima-media thickness, and the relationship to cardiovascular risk factors and peripheral arterial disease: the Ethnic-Echocardiographic Heart of England Screening Study.
QJM : monthly journal of the Association of Physicians 2011;104(3):245-54.
2011: A Ghattas; P-L Lip; G Y H Lip
Renin-angiotensin blockade in diabetic retinopathy.
International journal of clinical practice 2011;65(2):113-6.
2011: F D R Hobbs; G Y H Lip; Jonathan Mant; A K Roalfe; D A Fitzmaurice; K Fletcher
Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial.
BMJ (Clinical research ed.) 2011;342():d3653.
2011: C Muñoz-Esparza; Daniel Saura; Mariano Valdés; Diana Hernández-Romero; E Jover; G Y H Lip; Francisco Marin
Interactions between clopidogrel and proton pump inhibitors: a review of evidence.
Current medicinal chemistry 2011;18(16):2386-400.
2011: J V Patel; P S Gill; J Chackathayil; H Ojukwu; P Stemman; L Sheldon; S Meelu; D A Lane; I Tracey; G Y H Lip; E A Hughes
Short-term effects of screening for cardiovascular risk in the deaf community: a pilot study.
Cardiology research and practice 2011;2011():493546.
2011: Tjeerd P van Staa; Efrosini Setakis; G L Di Tanna; D A Lane; G Y H Lip
A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice.
Journal of thrombosis and haemostasis : JTH 2011;9(1):39-48.
2010: Neil S Roskell; G Y H Lip; Herbert Noack; Andreas Clemens; Jonathan M Plumb
Treatments for stroke prevention in atrial fibrillation: a network meta-analysis and indirect comparisons versus dabigatran etexilate.
Thrombosis and haemostasis 2010;104(6):1106-15.
2010: B Pamukcu; G Y H Lip
Insights from the new European Society of Cardiology guidelines for the medical management of atrial fibrillation.
International journal of clinical practice 2010;64(12):1587-90.
2010: Naglaa K Idriss; G Y H Lip; Balu Balakrishnan; Rumi Jaumdally; Christopher J Boos; Andrew D Blann
Plasma haemoxygenase-1 in coronary artery disease. A comparison with angiogenin, matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and vascular endothelial growth factor.
Thrombosis and haemostasis 2010;104(5):1029-37.
2010: Eduard Shantsila; P W Kamphuisen; G Y H Lip
Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis.
Journal of thrombosis and haemostasis : JTH 2010;8(11):2358-68.
2010: F Marín; G Y H Lip
Rhythm control agents and adverse events in patients with atrial fibrillation.
International journal of clinical practice 2010;64(10):1329-31.
2010: A Shantsila; G Y H Lip
Statins and prophylaxis of venous thrombosis - a further link between arterial and venous thrombosis.
International journal of clinical practice 2010;64(10):1326-8.
2010: Diana Hernández-Romero; Francisco Marín; Kaeng W Lee; Vanessa Roldán; Juan Caturla; Javier Corral; Mariano Valdés; G Y H Lip; Vicente Vicente; Rocío González-Conejero
Synergism between factor XII -4C>T and factor XIII Val34Leu polymorphisms in fibrinolytic therapy in acute myocardial infarction.
Thrombosis and haemostasis 2010;104(3):650-2.
2010: P C Bennett; G Y H Lip; S Silverman; Andrew D Blann; P S Gill
The contribution of cardiovascular risk factors to peripheral arterial disease in South Asians and Blacks: a sub-study to the Ethnic-Echocardiographic Heart of England Screening (E-ECHOES) study.
QJM : monthly journal of the Association of Physicians 2010;103(9):661-9.
2010: Timothy Watson; Eduard Shantsila; Andrew Blann; G Y H Lip
Circulating progenitor cells in patients with atrial fibrillation and their relation with serum markers of inflammation and angiogenesis.
Thrombosis and haemostasis 2010;104(2):327-34.
2010: Eduard Shantsila; Andrew Devitt; G Y H Lip
Circulating monocytes and atherogenesis: from animal experiments to human studies.
Thrombosis and haemostasis 2010;104(2):191-3.
2010: M Kowalczyk; Maciej Banach; G Y H Lip; D Kozłowski; Dimitri P Mikhailidis; Jacek Rysz
Levosimendan - a calcium sensitising agent with potential anti-arrhythmic properties.
International journal of clinical practice 2010;64(8):1148-54.
2010: Ingo Ahrens; G Y H Lip; Karlheinz Peter
New oral anticoagulant drugs in cardiovascular disease.
Thrombosis and haemostasis 2010;104(1):49-60.
2010: Diana Kaireviciute; Andrew D Blann; Balu Balakrishnan; Deirdre A Lane; Jeetesh Patel; Giedrius Uzdavinys; Gediminas Norkunas; Gintaras Kalinauskas; Vytautas Sirvydis; Audrius Aidietis; G Y H Lip
Characterisation and validity of inflammatory biomarkers in the prediction of post-operative atrial fibrillation in coronary artery disease patients.
Thrombosis and haemostasis 2010;104(1):122-7.
2010: A S Jaipersad; S H Silverman; G Y H Lip
Peripheral artery disease: appreciating the asymptomatic - yet lethal - epidemic.
International journal of clinical practice 2010;64(7):832-5.
2010: A S Jaipersad; Stanley H Silverman; G Y H Lip
Anti-platelet therapy: is it all over in peripheral artery disease?
Thrombosis and haemostasis 2010;103(4):689-91.
2010: G Y H Lip
Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at 'moderate risk' [CHADS2 score=1]: simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice.
Thrombosis and haemostasis 2010;103(4):683-5.
2010: Jeetesh Patel; M J Caslake; A Vyas; J Kennedy Cruickshank; Dorairaj Prabhakaran; D Bhatnagar; K S Reddy; G Y H Lip; M I Mackness; E A Hughes; Paul N Durrington
Triglycerides and small dense low density lipoprotein in the discrimination of coronary heart disease risk in South Asian populations.
Atherosclerosis 2010;209(2):579-84.
2010: R J Jaumdally; P K Y Goon; C Varma; A D Blann; G Y H Lip
Effects of atorvastatin on circulating CD34+/CD133+/ CD45- progenitor cells and indices of angiogenesis (vascular endothelial growth factor and the angiopoietins 1 and 2) in atherosclerotic vascular disease and diabetes mellitus.
Journal of internal medicine 2010;267(4):385-93.
2010: Karlheinz Peter; G Y H Lip
Changing the scope of preventative and therapeutic approaches in atherothrombosis.
Thrombosis and haemostasis 2010;103(3):487-8.
2010: T Watson; E Shantsila; V J Karthikeyan; S Jessani; P K Goon; G Y H Lip
The effects of exercise stress testing, diurnal variation and temporal decline on circulating progenitor cells.
Thrombosis and haemostasis 2010;103(2):419-25.
2010: D A Lane; G Y H Lip
Anticoagulation intensity for elderly atrial fibrillation patients: should we use a conventional INR target (2.0 to 3.0) or a lower range?
Thrombosis and haemostasis 2010;103(2):254-6.
2010: A Shantsila; G Y H Lip
Towards (cost)effective cardiovascular risk management: using new drugs vs. the better use of available ones.
International journal of clinical practice 2010;64(2):138-40.
2009: Eduard Shantsila; G Y H Lip
Systemic inflammation as a driver of vascular calcification: a proof of concept.
Journal of internal medicine 2009;266(5):453-6.
2009: D Saura; F Marín; V Climent; J González; V Roldán; D Hernández-Romero; M J Oliva; M Sabater; G de la Morena; G Y H Lip; M Valdés
Left atrial remodelling in hypertrophic cardiomyopathy: relation with exercise capacity and biochemical markers of tissue strain and remodelling.
International journal of clinical practice 2009;63(10):1465-71.
2009: S Krishnamoorthy; G Y H Lip
Renin-angiotensin-aldosterone system blockade in atrial fibrillation and left atrial remodelling.
International journal of clinical practice 2009;63(7):982-5.
2009: Rumi J Jaumdally; G Y H Lip; Jeetesh Patel; Robert J MacFadyen; Chetan Varma
Effects of coronary artery disease and percutaneous intervention on the cardiac metabolism of nonesterified fatty acids and insulin: Implications of diabetes mellitus.
Journal of internal medicine 2009;265(6):689-97.
2009: A Siddique; M Butt; Eduard Shantsila; G Y H Lip
New antiplatelet drugs: beyond aspirin and clopidogrel.
International journal of clinical practice 2009;63(5):776-89.
2009: Jeetesh Patel; A Abraheem; J Chackathayil; M Gunning; J Creamer; Elizabeth A Hughes; G Y H Lip
Circulating biomarkers of angiogenesis as indicators of left ventricular systolic dysfunction amongst patients with coronary artery disease.
Journal of internal medicine 2009;265(5):562-7.
2009: A Siddique; Eduard Shantsila; G Y H Lip
AZD6140 and bleeding: towards safer antiplatelet therapy?
International journal of clinical practice 2009;63(4):537-9.
2009: C W Khoo; K-H Tay; Eduard Shantsila; G Y H Lip
Novel oral anticoagulants.
International journal of clinical practice 2009;63(4):630-41.
2009: K H Tay; G Y H Lip; Deirdre Lane
Anticoagulation variability: is it the physician, patient or hospital?
Journal of internal medicine 2009;265(3):303-6.
2009: A D Blann; G Y H Lip
Plasma metalloproteinase-9 in age-related macular degeneration.
Eye (London, England) 2009;23(2):494-5; author reply 495.
2009: D Kaireviciute; A Aidietis; G Y H Lip
Pathophysiological insights into atrial fibrillation following cardiac surgery: implications for current pharmaceutical design.
Current pharmaceutical design 2009;15(29):3367-83.
2009: G Y H Lip; S Krishnamoorthy
Thrombosis prophylaxis in patients with ischaemic (cardioembolic) stroke. How long is long enough?
Hämostaseologie 2009;29(1):96-101.
2009: Kate Jolly; G Y H Lip; Rod S Taylor; James Raftery; Jonathan Mant; Deirdre Lane; Sheila Greenfield; Andrew J Stevens
The Birmingham Rehabilitation Uptake Maximisation study (BRUM): a randomised controlled trial comparing home-based with centre-based cardiac rehabilitation.
Heart (British Cardiac Society) 2009;95(1):36-42.
2008: C W Khoo; G Y H Lip
Radiofrequency catheter ablation of atrial fibrillation and thromboembolic risk.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2008;15(12):1261-2.
2008: Jeetesh Patel; A Abraheem; O Dotsenko; J Creamer; M Gunning; Elizabeth A Hughes; G Y H Lip
Circulating serum adiponectin levels in patients with coronary artery disease: relationship to atherosclerotic burden and cardiac function.
Journal of internal medicine 2008;264(6):593-8.
2008: Christopher J Boos; B Balakrishnan; Andrew D Blann; G Y H Lip
The relationship of circulating endothelial cells to plasma indices of endothelial damage/dysfunction and apoptosis in acute coronary syndromes: implications for prognosis.
Journal of thrombosis and haemostasis : JTH 2008;6(11):1841-50.
2008: J Sánchez-Quiñones; F Marín; V Roldán; G Y H Lip
The impact of statin use on atrial fibrillation.
QJM : monthly journal of the Association of Physicians 2008;101(11):845-61.
2008: Bethan Freestone; G Y H Lip
The endothelium and atrial fibrillation. The prothrombotic state revisited.
Hämostaseologie 2008;28(4):207-12.
2008: C W Khoo; G Y H Lip
Initiation and persistence of warfarin or aspirin as thromboprophylaxis in chronic atrial fibrillation in general practice.
Journal of thrombosis and haemostasis : JTH 2008;6(10):1622-4.
2008: G Y H Lip; Lars Frison; Margaretha Grind
Stroke event rates in anticoagulated patients with paroxysmal atrial fibrillation.
Journal of internal medicine 2008;264(1):50-61.
2008: A D Blann; A Choudhury; B Freestone; Jeetesh Patel; G Y H Lip
Soluble CD40 ligand and atrial fibrillation: relationship to platelet activation, and endothelial damage/dysfunction.
International journal of cardiology 2008;127(1):135-7.
2008: H S Lim; G Y H Lip
Circulating matrix metalloproteinase-9 levels in atherosclerotic vascular disease: a possible measurement of systemic or specific disease pathophysiology?
Journal of internal medicine 2008;263(6):620-2.
2008: Ray C Williams; A H Barnett; noel claffey; M Davis; R Gadsby; M Kellett; G Y H Lip; S Thackray
The potential impact of periodontal disease on general health: a consensus view.
Current medical research and opinion 2008;24(6):1635-43.
2008: Eduard Shantsila; G Y H Lip
Circulating endothelial cells in health and disease: how do we best quantify them?
Journal of thrombosis and haemostasis : JTH 2008;6(6):1021-4.
2008: G Dwivedi; Omer A Khair; G Y H Lip
Obstructive sleep apnoea and metabolic syndrome: two sides of the same coin?
Journal of human hypertension 2008;22(6):377-9.
2008: G Y H Lip; C J Boos
Antithrombotic treatment in atrial fibrillation.
Postgraduate medical journal 2008;84(991):252-8.
2008: Eduard Shantsila; Andrew D Blann; G Y H Lip
Circulating endothelial cells: from bench to clinical practice.
Journal of thrombosis and haemostasis : JTH 2008;6(5):865-8.
2008: G Mahadevan; Russell C Davis; Michael P Frenneaux; F D R Hobbs; G Y H Lip; J E Sanderson; Michael K Davies
Left ventricular ejection fraction: are the revised cut-off points for defining systolic dysfunction sufficiently evidence based?
Heart (British Cardiac Society) 2008;94(4):426-8.
2008: Andrew D Blann; Junette S Mohan; David Bareford; G Y H Lip
Soluble P-selectin and vascular endothelial growth factor in steady state sickle cell disease: relationship to genotype.
Journal of thrombosis and thrombolysis 2008;25(2):185-9.
2008: I Chung; Deepak Goyal; Robert J MacFadyen; G Y H Lip
The effects of maximal treadmill graded exercise testing on haemorheological, haemodynamic and flow cytometry platelet markers in patients with systolic or diastolic heart failure.
European journal of clinical investigation 2008;38(3):150-8.
2008: Jeetesh Patel; H S Lim; Ashan Gunarathne; I Tracey; Paul N Durrington; Elizabeth A Hughes; G Y H Lip
Ethnic differences in myocardial infarction in patients with hypertension: effects of diabetes mellitus.
QJM : monthly journal of the Association of Physicians 2008;101(3):231-6.
2008: I Chung; A Choudhury; Jeetesh Patel; G Y H Lip
Soluble CD40L, platelet surface CD40L and total platelet CD40L in congestive heart failure: relationship to platelet volume, mass and granularity.
Journal of internal medicine 2008;263(3):313-21.
2008: K Thornhill; Antonia C Lyons; Arie Nouwen; G Y H Lip
Experiences of living with congestive heart failure: a qualitative study.
British journal of health psychology 2008;13(Pt 1):155-75.
2008: Ashan Gunarathne; Jeetesh Patel; R Potluri; B Gammon; S Jessani; Elizabeth A Hughes; G Y H Lip
Increased 5-year mortality in the migrant South Asian stroke patients with diabetes mellitus in the United Kingdom: the West Birmingham Stroke Project.
International journal of clinical practice 2008;62(2):197-201.
2008: P K Y Goon; Timothy Watson; Paul S Stonelake; G Y H Lip
Endothelial progenitor cells: from pathophysiology to clinical practice.
International journal of clinical practice 2008;62(1):4-6.
2008: Ashan Gunarathne; Jeetesh Patel; R Potluri; P S Gill; Elizabeth A Hughes; G Y H Lip
Secular trends in the cardiovascular risk profile and mortality of stroke admissions in an inner city, multiethnic population in the United Kingdom (1997-2005).
Journal of human hypertension 2008;22(1):18-23.
2007: Antonio Tello-Montoliu; Francisco Marin; Vanessa Roldán; Luis Mainar; M T López; Francisco Sogorb; Vicente Vicente; G Y H Lip
A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
Journal of internal medicine 2007;262(6):651-8.
2007: K M Sharobeem; Jeetesh Patel; A E S Ritch; G Y H Lip; P S Gill; Elizabeth A Hughes
Elevated lipoprotein (a) and apolipoprotein B to AI ratio in South Asian patients with ischaemic stroke.
International journal of clinical practice 2007;61(11):1824-8.
2007: M Hughes; G Y H Lip
Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review.
QJM : monthly journal of the Association of Physicians 2007;100(10):599-607.
2007: VJ Karthikeyan; G Y H Lip
Peripheral artery disease and hypertension: the relation between ankle-brachial index and mortality.
Journal of human hypertension 2007;21(10):762-5.
2007: A Jordán; Vanessa Roldán; Miguel García; José V Monmeneu; Fernando García de Burgos; G Y H Lip; Francisco Marin
Matrix metalloproteinase-1 and its inhibitor, TIMP-1, in systolic heart failure: relation to functional data and prognosis.
Journal of internal medicine 2007;262(3):385-92.
2007: Deirdre Lane; G Y H Lip; D Gareth Beevers
Ethnic differences in cancer incidence and mortality: the Birmingham Factory Screening Project.
QJM : monthly journal of the Association of Physicians 2007;100(7):423-31.
2007: G Y H Lip; Lars Frison; Margaretha Grind
Angiotensin converting enzyme inhibitor and angiotensin receptor blockade use in relation to outcomes in anticoagulated patients with atrial fibrillation.
Journal of internal medicine 2007;261(6):577-86.
2007: Patrick K Y Goon; G Y H Lip
Involvement of circulating endothelial progenitor cells and vasculogenic factors in the pathogenesis of diabetic retinopathy.
Eye (London, England) 2007;21(6):838-9; author reply 838.
2007: G Y H Lip; G Agnelli; A A Thach; E Knight; D Rost; M J D Tangelder
Oral anticoagulation in atrial fibrillation: A pan-European patient survey.
European journal of internal medicine 2007;18(3):202-8.
2007: Eduard Shantsila; Timothy Watson; G Y H Lip
Antioxidant protection: yet another function of endothelial progenitor cells?
Journal of human hypertension 2007;21(5):343-6.
2007: Patrick K Y Goon; Timothy Watson; Eduard Shantsila; Christopher J Boos; G Y H Lip
Standardization of circulating endothelial cell enumeration by the use of human umbilical vein endothelial cells.
Journal of thrombosis and haemostasis : JTH 2007;5(4):870-2.
2007: S Jessani; K Gangopadhyay; Jeetesh Patel; G Y H Lip; TA Millane
Should oral glucose tolerance testing be mandatory following acute myocardial infarction?
International journal of clinical practice 2007;61(4):680-3.
2007: George I Varughese; Jeetesh Patel; Joseph Tomson; Andrew D Blann; Elizabeth A Hughes; G Y H Lip
Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial.
Journal of internal medicine 2007;261(4):384-91.
2007: Sunil Nadar; G Y H Lip
New insights into complement C3 and inflammation in hypertension.
Journal of human hypertension 2007;21(4):261-3.
2007: G Y H Lip; A H Barnett; Andrew Bradbury; F P Cappuccio; P S Gill; E Hughes; C Imray; Kate Jolly; K Patel
Ethnicity and cardiovascular disease prevention in the United Kingdom: a practical approach to management.
Journal of human hypertension 2007;21(3):183-211.
2007: C J Boos; Rumi J Jaumdally; R J MacFadyen; C Varma; G Y H Lip
Circulating endothelial cells and von Willebrand factor as indices of endothelial damage/dysfunction in coronary artery disease: a comparison of central vs. peripheral levels and effects of coronary angioplasty.
Journal of thrombosis and haemostasis : JTH 2007;5(3):630-2.
2007: S Jessani; G Y H Lip; A Barnett; TA Millane
The JBS-2 guidelines on prevention of cardiovascular disease in clinical practice: an opportunity missed.
QJM : monthly journal of the Association of Physicians 2007;100(2):121-4.
2007: Charles G C Spencer; Dirk C Felmeden; Andrew D Blann; G Y H Lip
Haemorheological, platelet and endothelial indices in relation to global measures of cardiovascular risk in hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Journal of internal medicine 2007;261(1):82-90.
2007: VJ Karthikeyan; G Y H Lip
N-terminal pro-brain natriuretic peptide and coronary artery disease.
European journal of clinical investigation 2007;37(1):1-7.
2007: V J Karthikeyan; G Y H Lip
Antihypertensive treatment, adiponectin and cardiovascular risk.
Journal of human hypertension 2007;21(1):8-11.
2007: N Sulke; F Sayers; G Y H Lip
Rhythm control and cardioversion.
Heart (British Cardiac Society) 2007;93(1):29-34.
2007: R I Dewar; G Y H Lip
Identification, diagnosis and assessment of atrial fibrillation.
Heart (British Cardiac Society) 2007;93(1):25-8.
2007: A John Camm; Irina Savelieva; G Y H Lip
Rate control in the medical management of atrial fibrillation.
Heart (British Cardiac Society) 2007;93(1):35-8.
2007: Lalit Kalra; G Y H Lip
Antithrombotic treatment in atrial fibrillation.
Heart (British Cardiac Society) 2007;93(1):39-44.
2007: CJ Mann; S Kendall; G Y H Lip
Acute management of atrial fibrillation with acute haemodynamic instability and in the postoperative setting.
Heart (British Cardiac Society) 2007;93(1):45-7.
2007: M Davis; S Rodgers; M Rudolf; M Hughes; G Y H Lip
Patient care pathway, implementation and audit criteria for patients with atrial fibrillation.
Heart (British Cardiac Society) 2007;93(1):48-52.
2007: G Y H Lip; M Rudolf
The new NICE guideline on atrial fibrillation management.
Heart (British Cardiac Society) 2007;93(1):23.
2007: Jeetesh Patel; Hoong Sern Lim; Elizabeth A Hughes; G Y H Lip
Adiponectin and hypertension: a putative link between adipocyte function and atherosclerotic risk?
Journal of human hypertension 2007;21(1):1-4.
2006: V J Karthikeyan; G Y H Lip
Oxidative stress and hypertension.
International journal of clinical practice 2006;60(12):1525-7.
2006: Christopher J Boos; G Y H Lip
Platelet activation and cardiovascular outcomes in acute coronary syndromes.
Journal of thrombosis and haemostasis : JTH 2006;4(12):2542-3.
2006: Puneet Kakar; G Y H Lip
Towards improving the clinical assessment and management of human hypertension: An overview from this Journal.
Journal of human hypertension 2006;20(12):913-6.
2006: K W Lee; Andrew D Blann; Kate Jolly; G Y H Lip
Plasma haemostatic markers, endothelial function and ambulatory blood pressure changes with home versus hospital cardiac rehabilitation: the Birmingham Rehabilitation Uptake Maximisation Study.
Heart (British Cardiac Society) 2006;92(12):1732-8.
2006: V J Karthikeyan; G Y H Lip
Aortic elasticity, left ventricular geometry and diastolic dysfunction in hypertension.
International journal of clinical practice 2006;60(11):1337-40.
2006: Puneet Kakar; G Y H Lip
Towards understanding the aetiology and pathophysiology of human hypertension: where are we now?
Journal of human hypertension 2006;20(11):833-6.
2006: C J Boos; F B Mayr; G Y H Lip; B Jilma
Endotoxemia enhances circulating endothelial cells in humans.
Journal of thrombosis and haemostasis : JTH 2006;4(11):2509-11.
2006: Patrick K Y Goon; F H Messerli; G Y H Lip
Hypertension and breast cancer: an association revisited?
Journal of human hypertension 2006;20(10):722-4.
2006: A Tello-Montoliu; Jeetesh Patel; G Y H Lip
Angiogenin: a review of the pathophysiology and potential clinical applications.
Journal of thrombosis and haemostasis : JTH 2006;4(9):1864-74.
2006: Jan Heeringa; Dwayne S G Conway; Deirdre A M van der Kuip; Albert Hofman; Monique Breteler; G Y H Lip; Jacqueline C M Witteman
A longitudinal population-based study of prothrombotic factors in elderly subjects with atrial fibrillation: the Rotterdam Study 1990-1999.
Journal of thrombosis and haemostasis : JTH 2006;4(9):1944-9.
2006: S Jessani; Timothy Watson; F P Cappuccio; G Y H Lip
Prevention of cardiovascular disease in clinical practice: The Joint British Societies' (JBS 2) guidelines.
Journal of human hypertension 2006;20(9):641-5.
2006: G I Varughese; Jeetesh Patel; G Y H Lip
Blood pressure control in the setting of diabetes mellitus: new targets, new hope for improvement?
Journal of human hypertension 2006;20(9):635-7.
2006: Timothy Watson; G Y H Lip
Blood pressure measurement in atrial fibrillation: goodbye mercury?
Journal of human hypertension 2006;20(9):638-40.
2006: Christopher J Boos; Patrick K Y Goon; G Y H Lip
Endothelial progenitor cells in the vascular pathophysiology of hypertension: arterial stiffness, ageing and more.
Journal of human hypertension 2006;20(7):475-7.
2006: Hoong Sern Lim; Jeetesh Patel; G Y H Lip
Reactive oxygen species production by circulating monocytes: insights from pathophysiology to clinical hypertension.
Journal of human hypertension 2006;20(5):307-9.
2006: V J Karthikeyan; G Y H Lip
White blood cell count and hypertension.
Journal of human hypertension 2006;20(5):310-2.
2006: J M Khan; R D S Watson; C Varma; T Millane; G Y H Lip
Do the National Institute of Clinical Excellence guidelines apply to 'real world' use of Abciximab in percutaneous coronary intervention in a teaching hospital setting?
International journal of clinical practice 2006;60(4):498-9.
2006: Patrick K Y Goon; G Y H Lip; C J Boos; Paul S Stonelake; Andrew D Blann
Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer.
Neoplasia (New York, N.Y.) 2006;8(2):79-88.
2006: G Y H Lip; C J Boos
Antithrombotic treatment in atrial fibrillation.
Heart (British Cardiac Society) 2006;92(2):155-61.
2006: I Chung; G Y H Lip
Antithrombotic therapy for congestive heart failure.
International journal of clinical practice 2006;60(1):36-47.
2006: Junette S Mohan; G Y H Lip; David Bareford; Andrew D Blann
Platelet P-selectin and platelet mass, volume and component in sickle cell disease: relationship to genotype.
Thrombosis research 2006;117(6):623-9.
2005: Kiat T Tan; Muzahir H Tayebjee; Hoong Sern Lim; G Y H Lip
Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.
Diabetic medicine : a journal of the British Diabetic Association 2005;22(12):1657-62.
2005: Muzahir H Tayebjee; G Y H Lip; Robert J MacFadyen
What role do extracellular matrix changes contribute to the cardiovascular disease burden of diabetes mellitus?
Diabetic medicine : a journal of the British Diabetic Association 2005;22(12):1628-35.
2005: G I Varughese; Jeetesh Patel; Joseph Tomson; G Y H Lip
The prothrombotic risk of diabetes mellitus in atrial fibrillation and heart failure.
Journal of thrombosis and haemostasis : JTH 2005;3(12):2811-3.
2005: H S Lim; Muzahir H Tayebjee; K T Tan; Jeetesh Patel; R J Macfadyen; G Y H Lip
Serum adiponectin in coronary heart disease: ethnic differences and relation to coronary artery disease severity.
Heart (British Cardiac Society) 2005;91(12):1605-6.
2005: Robert J MacFadyen; Deepak Goyal; G Y H Lip
How far can population epidemiology contribute to defining the relationship between hypertension and left ventricular systolic dysfunction?
Journal of human hypertension 2005;19(12):919-22.
2005: Christopher J Boos; G Y H Lip
Targeting the renin-angiotensin-aldosterone system in atrial fibrillation: from pathophysiology to clinical trials.
Journal of human hypertension 2005;19(11):855-9.
2005: G I Varughese; G Y H Lip
Antihypertensive therapy in diabetes mellitus: insights from ALLHAT and the Blood Pressure-Lowering Treatment Trialists' Collaboration meta-analysis.
Journal of human hypertension 2005;19(11):851-3.
2005: K W Lee; Andrew D Blann; J Ingram; Kate Jolly; G Y H Lip
Incremental shuttle walking is associated with activation of haemostatic and haemorheological markers in patients with coronary artery disease: the Birmingham rehabilitation uptake maximization study (BRUM).
Heart (British Cardiac Society) 2005;91(11):1413-7.
2005: Sunil Nadar; Andrew D Blann; D Gareth Beevers; G Y H Lip
Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].
Journal of internal medicine 2005;258(4):336-43.
2005: Muzahir H Tayebjee; G Y H Lip; Robert J MacFadyen
Is there an association between hypertension and the development of coronary collateral flow?
Journal of human hypertension 2005;19(10):757-9.
2005: Rumi J Jaumdally; G Y H Lip; C Varma
Percutaneous coronary interventions for coronary artery disease: the long and short of optimizing medical therapy.
International journal of clinical practice 2005;59(9):1070-81.
2005: Dirk C Felmeden; Sunil Nadar; G Y H Lip
Aspirin and endothelial function in hypertension.
Journal of human hypertension 2005;19(9):663-5.
2005: C J Boos; A Hinton; G Y H Lip
Ximelagatran: a clinical perspective.
European journal of internal medicine 2005;16(4):267-78.
2005: A Choudhury; G Y H Lip
Exercise and hypertension.
Journal of human hypertension 2005;19(8):585-7.
2005: Junette S Mohan; Peck Lin Lip; Andrew D Blann; David Bareford; G Y H Lip
The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment.
The British journal of ophthalmology 2005;89(7):815-9.
2005: George I Varughese; Joseph Tomson; G Y H Lip
Type 2 diabetes mellitus: a cardiovascular perspective.
International journal of clinical practice 2005;59(7):798-816.
2005: Christopher J Boos; G Y H Lip
Elevated high-sensitive C-reactive protein, large arterial stiffness and atherosclerosis: a relationship between inflammation and hypertension?
Journal of human hypertension 2005;19(7):511-3.
2005: G Y H Lip; Lesly A Pearce; Bernard S P Chin; Dwayne S G Conway; Robert Hart
Effects of congestive heart failure on plasma von Willebrand factor and soluble P-selectin concentrations in patients with non-valvar atrial fibrillation.
Heart (British Cardiac Society) 2005;91(6):759-63.
2005: G I Varughese; G Y H Lip
Hypertension in patients with type-II diabetes: relation to urinary albumin excretion, endothelial function and inflammation.
Journal of human hypertension 2005;19(6):421-4.
2005: H S Lim; G Y H Lip; D G Beevers; Andrew D Blann
Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension.
European journal of clinical investigation 2005;35(5):324-9.
2005: G Y H Lip; W Foster; Andrew D Blann
Plasma von Willebrand factor levels and surrogates of atherosclerosis.
Journal of thrombosis and haemostasis : JTH 2005;3(4):659-61.
2005: Deirdre Lane; C Ring; G Y H Lip; D Carroll
Depression, indirect clinical markers of cardiac disease severity, and mortality following myocardial infarction.
Heart (British Cardiac Society) 2005;91(4):531-2.
2005: A Choudhury; G Y H Lip
How good is anticoagulation control in non-valvar atrial fibrillation? Observations on the elderly, ethnicity, patient perceptions, and understanding of AF thromboprophylaxis.
Heart (British Cardiac Society) 2005;91(4):425-6.
2005: Graham J Caine; Adrian L Harris; K Christodoulos; G Y H Lip; Andrew D Blann
Analysis of combination anti-angiogenesis therapy on markers of coagulation, platelet activation and angiogenesis in patients with advanced cancer.
Cancer letters 2005;219(2):163-7.
2005: Hoong Sern Lim; Aun Yeong Chong; Bethan Freestone; Andrew D Blann; G Y H Lip
The effect of multi-factorial intervention on plasma von Willebrand factor, soluble E-selectin and tissue factor in diabetes mellitus: implications for atherosclerotic vascular disease.
Diabetic medicine : a journal of the British Diabetic Association 2005;22(3):249-55.
2005: Dirk C Felmeden; G Y H Lip
Antithrombotic therapy in hypertension: a Cochrane Systematic review.
Journal of human hypertension 2005;19(3):185-96.
2005: Patrick K Y Goon; Christopher J Boos; G Y H Lip
Circulating endothelial cells: markers of vascular dysfunction.
Clinical laboratory 2005;51(9-10):531-8.
2005: Deirdre Lane; Aun Yeong Chong; G Y H Lip
Psychological interventions for depression in heart failure.
Cochrane database of systematic reviews (Online) 2005;(1):CD003329.
2005: Muzahir H Tayebjee; H S Lim; Sunil Nadar; Robert J MacFadyen; G Y H Lip
Tissue inhibitor of metalloproteinse-1 is a marker of diastolic dysfunction using tissue doppler in patients with type 2 diabetes and hypertension.
European journal of clinical investigation 2005;35(1):8-12.
2005: Muzahir H Tayebjee; Kiat T Tan; Robert J MacFadyen; G Y H Lip
Abnormal circulating levels of metalloprotease 9 and its tissue inhibitor 1 in angiographically proven peripheral arterial disease: relationship to disease severity.
Journal of internal medicine 2005;257(1):110-6.
2005: Sunil Nadar; D Gareth Beevers; G Y H Lip
Echocardiographic changes in patients with malignant phase hypertension: the West Birmingham Malignant Hypertension Register.
Journal of human hypertension 2005;19(1):69-75.
2004: PL Lip; S Chatterjee; Graham J Caine; MW Hope-Ross; J Gibson; Andrew D Blann; G Y H Lip
Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.
The British journal of ophthalmology 2004;88(12):1543-6.
2004: Francisco Marin; Vanessa Roldán; Vicente Climent; A Ibáñez; Amaya García; Pascual Marco; Francisco Sogorb; G Y H Lip
Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillation.
Heart (British Cardiac Society) 2004;90(10):1162-6.
2004: Sunil Nadar; Andrew D Blann; G Y H Lip
Plasma and platelet-derived vascular endothelial growth factor and angiopoietin-1 in hypertension: effects of antihypertensive therapy.
Journal of internal medicine 2004;256(4):331-7.
2004: G Y H Lip; H Khan; A Bhatnagar; N Brahmabhatt; P Crook; M K Davies
Ethnic differences in patient perceptions of heart failure and treatment: the West Birmingham heart failure project.
Heart (British Cardiac Society) 2004;90(9):1016-9.
2004: Charles G C Spencer; D Gareth Beevers; G Y H Lip
Ethnic differences in left ventricular size and the prevalence of left ventricular hypertrophy among hypertensive patients vary with electrocardiographic criteria.
Journal of human hypertension 2004;18(9):631-6.
2004: G Thrall; G Y H Lip; Deirdre Lane
Compliance with pharmacological therapy in hypertension: can we do better, and how?
Journal of human hypertension 2004;18(9):595-7.
2004: FJ Hoar; G Y H Lip; Funmi M Belgore; Paul S Stonelake
Circulating levels of VEGF-A, VEGF-D and soluble VEGF-A receptor (sFIt-1) in human breast cancer.
The International journal of biological markers 2004;19(3):229-35.
2004: Hoong Sern Lim; G Y H Lip
Arterial stiffness in diabetes and hypertension.
Journal of human hypertension 2004;18(7):467-8.
2004: Bethan Freestone; D Gareth Beevers; G Y H Lip
The renin-angiotensin-aldosterone system in atrial fibrillation: a new therapeutic target?
Journal of human hypertension 2004;18(7):461-5.
2004: Muzahir H Tayebjee; S P Singh; G Y H Lip
Autonomic reflexes in heterotopic heart transplantation.
International journal of clinical practice 2004;58(5):520-2.
2004: Muzahir H Tayebjee; G Y H Lip; Robert J MacFadyen
Collateralization and the response to obstruction of epicardial coronary arteries.
QJM : monthly journal of the Association of Physicians 2004;97(5):259-72.
2004: Kiat T Tan; S P Watson; G Y H Lip
The endothelium and platelets in cardiovascular disease: potential targets for therapeutic intervention.
Current medicinal chemistry. Cardiovascular and hematological agents 2004;2(2):169-78.
2004: H S Lim; G Y H Lip
Impaired fasting glycaemia vs. impaired glucose tolerance: two sides of the same coin with implications for cardiovascular risk.
Diabetic medicine : a journal of the British Diabetic Association 2004;21(4):303-4.
2004: Funmi M Belgore; Andrew D Blann; D Neil; A S Ahmed; G Y H Lip
Localisation of members of the vascular endothelial growth factor (VEGF) family and their receptors in human atherosclerotic arteries.
Journal of clinical pathology 2004;57(3):266-72.
2004: G Y H Lip; D C Felmeden
Antiplatelet agents and anticoagulants for hypertension.
Cochrane database of systematic reviews (Online) 2004;(3):CD003186.
2004: Janine Dretzke; W D Toff; G Y H Lip; James Raftery; Anne Fry-Smith; Rod S Taylor
Dual chamber versus single chamber ventricular pacemakers for sick sinus syndrome and atrioventricular block.
Cochrane database of systematic reviews (Online) 2004;(2):CD003710.
2004: Aun Yeong Chong; Graham J Caine; G Y H Lip
Angiopoietin/tie-2 as mediators of angiogenesis: a role in congestive heart failure?
European journal of clinical investigation 2004;34(1):9-13.
2004: Charles G C Spencer; David Gurney; Dirk C Felmeden; Andrew D Blann; D Gareth Beevers; G Y H Lip
Platelet and haemorheological markers in 'high risk' hypertensives are improved by tighter blood pressure control and cardiovascular risk management: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Journal of internal medicine 2004;255(1):59-67.
2003: Natali A Y Chung; C Lydakis; Funmi M Belgore; Foo Leong Li-Saw-Hee; Andrew D Blann; G Y H Lip
Angiogenesis, thrombogenesis, endothelial dysfunction and angiographic severity of coronary artery disease.
Heart (British Cardiac Society) 2003;89(12):1411-5.
2003: Bernard S P Chin; Andrew D Blann; Christopher R Gibbs; Natali A Y Chung; D G Conway; G Y H Lip
Prognostic value of interleukin-6, plasma viscosity, fibrinogen, von Willebrand factor, tissue factor and vascular endothelial growth factor levels in congestive heart failure.
European journal of clinical investigation 2003;33(11):941-8.
2003: G Y H Lip; D Gareth Beevers
More evidence on blocking the renin-angiotensin-aldosterone system in cardiovascular disease and the long-term treatment of hypertension: data from recent clinical trials (CHARM, EUROPA, ValHEFT, HOPE-TOO and SYST-EUR2).
Journal of human hypertension 2003;17(11):747-50.
2003: Bethan Freestone; R Rajaratnam; N Hussain; G Y H Lip
Admissions with atrial fibrillation in a multiracial population in Kuala Lumpur, Malaysia.
International journal of cardiology 2003;91(2-3):233-8.
2003: Graham J Caine; Andrew D Blann; Paul S Stonelake; Peter Ryan; G Y H Lip
Plasma angiopoietin-1, angiopoietin-2 and Tie-2 in breast and prostate cancer: a comparison with VEGF and Flt-1.
European journal of clinical investigation 2003;33(10):883-90.
2003: Funmi M Belgore; G Y H Lip; Andrew D Blann
Basic fibrobrast growth factor induces the secretion of vascular endothelial growth factor by human aortic smooth muscle cells but not by endothelial cells.
European journal of clinical investigation 2003;33(10):833-9.
2003: S Kamath; G Y H Lip
Fibrinogen: biochemistry, epidemiology and determinants.
QJM : monthly journal of the Association of Physicians 2003;96(10):711-29.
2003: Michael D Sosin; Gurbir S Bhatia; Russell C Davis; Derek L Connolly; G Y H Lip
Heart failure: treatment and ethnic origin.
Lancet 2003;362(9387):919-20.
2003: S Kamath; A D Blann; B S P Chin; G Y H Lip
Platelet activation, haemorheology and thrombogenesis in acute atrial fibrillation: a comparison with permanent atrial fibrillation.
Heart (British Cardiac Society) 2003;89(9):1093-5.
2003: Kaeng W Lee; G Y H Lip
The role of omega-3 fatty acids in the secondary prevention of cardiovascular disease.
QJM : monthly journal of the Association of Physicians 2003;96(7):465-80.
2003: Dirk C Felmeden; Andrew D Blann; Charles G C Spencer; D Gareth Beevers; G Y H Lip
A comparison of flow-mediated dilatation and von Willebrand factor as markers of endothelial cell function in health and in hypertension: relationship to cardiovascular risk and effects of treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2003;14(5):425-31.
2003: Natali A Y Chung; Andrew J Makin; G Y H Lip
Measurement of the soluble angiopoietin receptor tie-2 in patients with coronary artery disease: development and application of an immunoassay.
European journal of clinical investigation 2003;33(7):529-35.
2003: D Gareth Beevers; K W Lee; G Y H Lip
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): ALL predictable, and no big surprise out of a HAT?
Journal of human hypertension 2003;17(6):367-72.
2003: K W Lee; G Y H Lip
Insulin resistance and vascular remodelling, in relation to left ventricular mass, geometry and function: an answer to LIFE?
Journal of human hypertension 2003;17(5):299-304.
2003: Dirk C Felmeden; Andrew D Blann; G Y H Lip
Angiogenesis: basic pathophysiology and implications for disease.
European heart journal 2003;24(7):586-603.
2003: Aun Yeong Chong; Andrew D Blann; G Y H Lip
Assessment of endothelial damage and dysfunction: observations in relation to heart failure.
QJM : monthly journal of the Association of Physicians 2003;96(4):253-67.
2003: Aun Yeong Chong; Carl Clarke; W R Dimitri; G Y H Lip
Brachial plexus injury as an unusual complication of coronary artery bypass graft surgery.
Postgraduate medical journal 2003;79(928):84-6.
2003: G Y H Lip; Andrew J Makin
Treatment of hypertension in peripheral arterial disease.
Cochrane database of systematic reviews (Online) 2003;(4):CD003075.
2003: G Y H Lip; Deirdre Lane; TA Millane; Muzahir H Tayebjee
Psychological interventions for depression in adolescent and adult congenital heart disease.
Cochrane database of systematic reviews (Online) 2003;(3):CD004394.
2003: Dirk C Felmeden; Charles G C Spencer; Andrew D Blann; D Gareth Beevers; G Y H Lip
Physical activity in relation to indices of endothelial function and angiogenesis factors in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Journal of internal medicine 2003;253(1):81-91.
2002: Sunil Nadar; Hoong Sern Lim; D Gareth Beevers; G Y H Lip
Lipid lowering in hypertension and heart protection: observations from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) and the Heart Protection Study.
Journal of human hypertension 2002;16(12):815-7.
2002: G J Caine; G Y H Lip
Dietary prevention of carcinogenesis in smokers.
Journal of internal medicine 2002;252(6):577-8.
2002: A D Blann; G Y H Lip; C N McCollum
Changes in von Willebrand factor and soluble ICAM, but not soluble VCAM, soluble E selectin or soluble thrombomodulin, reflect the natural history of the progression of atherosclerosis.
Atherosclerosis 2002;165(2):389-91.
2002: Graham J Caine; Sean T Kehoe; G Y H Lip
The role of aspirin in carcinogenesis.
British journal of cancer 2002;87(11):1337-8.
2002: Andrew J Makin; Stanley H Silverman; G Y H Lip
Ethnicity and peripheral vascular disease.
International journal of clinical practice 2002;56(9):645-8.
2002: Sridhar Kamath; Andrew D Blann; Bernard S P Chin; F Lanza; B Aleil; J P Cazenave; G Y H Lip
A study of platelet activation in atrial fibrillation and the effects of antithrombotic therapy.
European heart journal 2002;23(22):1788-95.
2002: Peck Lin Lip; Dirk C Felmeden; Andrew D Blann; N Matheou; S Thakur; I A Cunliffe; G Y H Lip
Plasma vascular endothelial growth factor, soluble VEGF receptor FLT-1, and von Willebrand factor in glaucoma.
The British journal of ophthalmology 2002;86(11):1299-302.
2002: Andrew D Blann; NR Williams; G Y H Lip; J Rajput-Williams; AN Howard
Acute ingestion of red wine by men activates platelets but does not influence endothelial markers: no effect of white wine.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2002;13(7):647-51.
2002: S Kamath; B S P Chin; A D Blann; G Y H Lip
A study of platelet activation in paroxysmal, persistent and permanent atrial fibrillation.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2002;13(7):627-36.
2002: Andrew J Makin; S Silverman; G Y H Lip
Ethnic differences in peripheral vascular disease.
International journal of clinical practice 2002;56(8):605-8.
2002: Sunil Nadar; G Y H Lip
Secular trends in cardiovascular disease.
Journal of human hypertension 2002;16(10):663-6.
2002: Natali A Y Chung; C Lydakis; Funmi M Belgore; Andrew D Blann; G Y H Lip
Angiogenesis in myocardial infarction. An acute or chronic process?
European heart journal 2002;23(20):1604-8.
2002: A D Blann; G Y H Lip; C N McCollum
Influence of the risk factors for atherosclerosis on levels of soluble adhesion molecules and endothelial markers in peripheral vascular disease.
Thrombosis and haemostasis 2002;88(2):366-7.
2002: D C Felmeden; D G Beevers; G Y H Lip
Tackling malignant hypertension: not so desperate now.
American heart journal 2002;144(2):E4.
2002: Bernd Jilma; F L Li-Saw-Hee; Oswald F Wagner; D G Beevers; G Y H Lip
Effects of enalapril and losartan on circulating adhesion molecules and monocyte chemotactic protein-1.
Clinical science (London, England : 1979) 2002;103(2):131-6.
2002: K W Lee; B Freestone; L Harris; G Y H Lip
HRT in a general practice population: further observations on the 'healthy cohort' effect.
International journal of clinical practice 2002;56(6):486-7.
2002: G Y H Lip; Christopher R Gibbs
Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review.
QJM : monthly journal of the Association of Physicians 2002;95(7):461-8.
2002: G Y H Lip; Christopher R Gibbs
Anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review.
QJM : monthly journal of the Association of Physicians 2002;95(7):451-9.
2002: Deirdre Lane; G Y H Lip; TA Millane
Quality of life in adults with congenital heart disease.
Heart (British Cardiac Society) 2002;88(1):71-5.
2002: Bernard S P Chin; Aun Yeong Chong; G Y H Lip
A case of resistant hypertension in a 69-year-old man.
Journal of human hypertension 2002;16(6):445-7.
2002: G Y H Lip; Andrew D Blann; I S Farooqi; J Zarifis; G Sagar; D Gareth Beevers
Sequential alterations in haemorheology, endothelial dysfunction, platelet activation and thrombogenesis in relation to prognosis following acute stroke: The West Birmingham Stroke Project.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2002;13(4):339-47.
2002: G Y H Lip; E Edmunds; S L Nuttall; Martin J Landray; Andrew D Blann; D Gareth Beevers
Oxidative stress in malignant and non-malignant phase hypertension.
Journal of human hypertension 2002;16(5):333-6.
2002: G Y H Lip
Losartan and the meaning of LIFE.
Journal of human hypertension 2002;16(5):289-91.
2002: C M Langman; Antonia C Lyons; G Y H Lip
'You cannot be serious!' compliance and antihypertensive regimens.
International journal of clinical practice 2002;56(3):164-6.
2002: Deirdre Lane; D Gareth Beevers; G Y H Lip
Ethnic differences in blood pressure and the prevalence of hypertension in England.
Journal of human hypertension 2002;16(4):267-73.
2002: Andrew J Makin; Stanley H Silverman; G Y H Lip
Peripheral vascular disease and Virchow's triad for thrombogenesis.
QJM : monthly journal of the Association of Physicians 2002;95(4):199-210.
2002: L L Tin; D Gareth Beevers; G Y H Lip
Systolic vs diastolic blood pressure and the burden of hypertension.
Journal of human hypertension 2002;16(3):147-50.
2002: Martin J Landray; E Edmunds; Foo Leong Li-Saw-Hee; Beverly A Hughes; D Gareth Beevers; Martin J Kendall; G Y H Lip
Abnormal low-density lipoprotein subfraction profile in patients with untreated hypertension.
QJM : monthly journal of the Association of Physicians 2002;95(3):165-71.
2002: Andrew D Blann; I C Nitu-Whalley; C A Lee; G Y H Lip
Inverse relationship between plasma von Willebrand factor and soluble P selectin in patients with type 1 but not type 2 von Willebrand disease.
American journal of hematology 2002;69(2):135-7.
2002: G Y H Lip; Andrew D Blann; E Edmunds; D Gareth Beevers
Baseline abnormalities of endothelial function and thrombogenesis in relation to prognosis in essential hypertension.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2002;13(1):35-41.
2002: Graham J Caine; D G Beevers; G Y H Lip
Cancer and ethnic minorities.
The lancet oncology 2002;3(1):9.